Global obesity is on the rise, and endocrinologists are at the forefront of diagnosing its underlying causes and prescribing treatment plans. The Society works to reduce prevalence of obesity through various means, including development and release of scientific statements and practice guidelines, and advocacy for policies and positions that ensure access to affordable treatments. As new obesity medications come to market, the Society will play an important role in educating providers and patients on their optimal usage.
BREAKING NEWS! Join Patient Perspectives on Medical Treatment of Obesity: Help shape medical practice guidelines. What patients share during the Listening Session will be carefully considered by the Endocrine Society’s panel of medical professionals as part of the guideline development process.